Achillion Pharmaceuticals, Inc.
www.alexion.comOn January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”
Read more
On January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”
Read more
Country
State
Pennsylvania
Industry
Estimated Revenue
$250,000,000 to $500,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President and Head Clinical Operations and Project Management
Email ****** @****.comPhone (***) ****-****President / Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Operating Officer
Email ****** @****.comPhone (***) ****-****Chairman
Email ****** @****.comPhone (***) ****-****
Technologies
(77)
Reach decision makers at Achillion Pharmaceuticals, Inc.
Free credits every month!
Achillion Pharmaceuticals, Inc. FAQ
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
